Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rüegg

Showing results (41-50 of 107) with videos related to

Pageof 11
Sort By:
Development (Cambridge, England)|March 16, 2019
mTOR controls embryonic and adult myogenesis via mTORC1Nathalie Rion, Perrine Castets, Shuo Lin, et al.
Nature Cell Biology|October 7, 2004
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitiveEstela Jacinto, Robbie Loewith, Anja Schmidt, et al.
Cell and Tissue Research|August 10, 2014
The heparan sulfate proteoglycan agrin contributes to barrier properties of mouse brain endothelial cells by stabilizing adherens junctionsEsther Steiner, Gaby U Enzmann, Ruth Lyck, et al.
Experimental Eye Research|April 19, 2015
Loss of mTOR signaling affects cone function, cone structure and expression of cone specific proteins without affecting cone survivalShan Ma, Aditya Venkatesh, Fernanda Langellotto, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 11, 2005
Src-family kinases stabilize the neuromuscular synapse in vivo via protein interactions, phosphorylation, and cytoskeletal linkage of acetylcholine receptorsGayathri Sadasivam, Raffaella Willmann, Shuo Lin, et al.
The Journal of Clinical Investigation|February 21, 2017
Chimeric protein repair of laminin polymerization ameliorates muscular dystrophy phenotypeKaren K McKee, Stephanie C Crosson, Sarina Meinen, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2009
Omigapil ameliorates the pathology of muscle dystrophy caused by laminin-alpha2 deficiencyMichael Erb, Sarina Meinen, Patrizia Barzaghi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 3, 2013
Inactivation of mTORC1 in the developing brain causes microcephaly and affects gliogenesisDimitri Cloëtta, Venus Thomanetz, Constanze Baranek, et al.
The Journal of Cell Biology|April 10, 2013
Ablation of the mTORC2 component rictor in brain or Purkinje cells affects size and neuron morphologyVenus Thomanetz, Nico Angliker, Dimitri Cloëtta, et al.
Nature Communications|November 4, 2016
mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formationXiaolei Ding, Wilhelm Bloch, Sandra Iden, et al.
Pageof 11

Showing results (41-50 of 107) with videos related to

Sort By:
Pageof 11
Development (Cambridge, England)|March 16, 2019
mTOR controls embryonic and adult myogenesis via mTORC1Nathalie Rion, Perrine Castets, Shuo Lin, et al.
Nature Cell Biology|October 7, 2004
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitiveEstela Jacinto, Robbie Loewith, Anja Schmidt, et al.
Cell and Tissue Research|August 10, 2014
The heparan sulfate proteoglycan agrin contributes to barrier properties of mouse brain endothelial cells by stabilizing adherens junctionsEsther Steiner, Gaby U Enzmann, Ruth Lyck, et al.
Experimental Eye Research|April 19, 2015
Loss of mTOR signaling affects cone function, cone structure and expression of cone specific proteins without affecting cone survivalShan Ma, Aditya Venkatesh, Fernanda Langellotto, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 11, 2005
Src-family kinases stabilize the neuromuscular synapse in vivo via protein interactions, phosphorylation, and cytoskeletal linkage of acetylcholine receptorsGayathri Sadasivam, Raffaella Willmann, Shuo Lin, et al.
The Journal of Clinical Investigation|February 21, 2017
Chimeric protein repair of laminin polymerization ameliorates muscular dystrophy phenotypeKaren K McKee, Stephanie C Crosson, Sarina Meinen, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2009
Omigapil ameliorates the pathology of muscle dystrophy caused by laminin-alpha2 deficiencyMichael Erb, Sarina Meinen, Patrizia Barzaghi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 3, 2013
Inactivation of mTORC1 in the developing brain causes microcephaly and affects gliogenesisDimitri Cloëtta, Venus Thomanetz, Constanze Baranek, et al.
The Journal of Cell Biology|April 10, 2013
Ablation of the mTORC2 component rictor in brain or Purkinje cells affects size and neuron morphologyVenus Thomanetz, Nico Angliker, Dimitri Cloëtta, et al.
Nature Communications|November 4, 2016
mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formationXiaolei Ding, Wilhelm Bloch, Sandra Iden, et al.
Pageof 11